4-Hydroxyglutamate is a novel predictor of pre-eclampsia

BACKGROUND: Pre-term pre-eclampsia is a major cause of maternal and perinatal morbidity and mortality worldwide. A multi-centre randomized–controlled trial has shown that first-trimester screening followed by treatment of high-risk women with aspirin reduces the risk of pre-term pre-eclampsia. Howev...

Descripción completa

Detalles Bibliográficos
Autores principales: Sovio, Ulla, McBride, Nancy, Wood, Angela M, Masconi, Katya L, Cook, Emma, Gaccioli, Francesca, Charnock-Jones, D Stephen, Lawlor, Debbie A, Smith, Gordon C S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Miscellaneous
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7124498/
https://www.ncbi.nlm.nih.gov/pubmed/31098639
http://dx.doi.org/10.1093/ije/dyz098

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7124498/
https://www.ncbi.nlm.nih.gov/pubmed/31098639
http://dx.doi.org/10.1093/ije/dyz098

Ejemplares similares